Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Revenue (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Revenue for 16 consecutive years, with $15.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue fell 43.75% year-over-year to $15.9 million, compared with a TTM value of $75.6 million through Sep 2025, down 23.6%, and an annual FY2024 reading of $101.5 million, up 21.38% over the prior year.
  • Revenue was $15.9 million for Q3 2025 at Rockwell Medical, down from $16.1 million in the prior quarter.
  • Across five years, Revenue topped out at $28.3 million in Q3 2024 and bottomed at $15.1 million in Q2 2021.
  • Average Revenue over 5 years is $19.5 million, with a median of $18.7 million recorded in 2022.
  • The sharpest move saw Revenue skyrocketed 42.88% in 2024, then crashed 43.75% in 2025.
  • Year by year, Revenue stood at $15.3 million in 2021, then grew by 25.96% to $19.3 million in 2022, then increased by 14.39% to $22.1 million in 2023, then increased by 11.64% to $24.7 million in 2024, then tumbled by 35.43% to $15.9 million in 2025.
  • Business Quant data shows Revenue for RMTI at $15.9 million in Q3 2025, $16.1 million in Q2 2025, and $18.9 million in Q1 2025.